Tableau de bordPortefeuillesListe de surveillanceCommunautéDécouvrirFiltre
NOT FOR DISTRIBUTION

FIGS, Inc.

NYSE:FIGS Rapport sur les actions

Capitalisation boursière : US$2.2b

  • Présentation de l'entreprise
    • Évaluation
    • Croissance future
    • Performances passées
    • Santé financière
    • Dividende
  • Gestion
  • Propriété
  • Autres informations
  • Communauté boursière

FIGS Résultats passés

Passé contrôle des critères 5/6

FIGS a connu une croissance annuelle moyenne de ses bénéfices de 33.5%, tandis que le secteur Luxury a vu ses bénéfices augmenter de en baisse à 0.3% par an. Les revenus ont augmenté de en hausse à un taux moyen de 9.9% par an. Le rendement des capitaux propres de FIGS est 14% et ses marges nettes sont de 8.7%.

Informations clés

33.53%

Taux de croissance des bénéfices

33.74%

Taux de croissance du BPA

Luxury Croissance de l'industrie12.25%
Taux de croissance des recettes9.91%
Rendement des fonds propres14.00%
Marge nette8.72%
Dernière mise à jour des bénéfices30 Jun 2026

Mises à jour récentes des performances passées

Recent updates

User avatar
Mise à jour du récit • Aug 23

FIGS: International Expansion And Margin Strength Are Expected To Drive Future Upside

Analysts have raised the FIGS fair value estimate by $1.00 to $18.63, reflecting a mix of higher long term P/E assumptions and recent price target revisions around $16 to $22 that balance strong recent results with concerns about macro uncertainty and supply chain risks. Analyst Commentary Recent research on FIGS shows a mix of optimism about execution and growth, alongside concern about external risks and how much is already reflected in the stock price.
User avatar
Mise à jour du récit • Aug 07

FIGS: Future Returns Will Reflect Balanced Execution Strength And External Risk

For FIGS, the updated analyst fair value estimate has moved from $14.00 to $15.00 per share. This reflects recent Street price target revisions around $16.00 to $22.00 that are based on strong quarterly results but tempered by global macro and supply chain risks.
Seeking Alpha • Aug 02

FIGS Makes For A Better Fit Now (Rating Upgrade)

Summary FIGS, Inc. is upgraded from ‘sell’ to ‘hold’ as valuation now reflects fair value after a 16% share price decline and continued growth. FIGS delivered 28% YoY revenue growth in Q1 2026, driven by a 12% increase in active customers and higher net revenue per customer. Management guides for 14–16% revenue growth and a 27.7% EBITDA increase in 2026, supported by a strong net cash position of $277 million. While industry headwinds and economic uncertainty persist, FIGS’ diversified channels and international expansion underpin cautious optimism for continued performance. Read the full article on Seeking Alpha
User avatar
Mise à jour du récit • Jul 08

FIGS: Higher Profitability Assumptions Will Support Stronger Future Share Performance

The fair value estimate for FIGS has been raised from $6.20 to $14.00. This change reflects analysts' updated assumptions for higher revenue growth, stronger profit margins, and a richer future P/E multiple.
User avatar
Mise à jour du récit • Jun 24

FIGS: Execution And 2026 Outlook Are Expected To Sustain Upside Potential

Analysts raised their price target on FIGS by a few dollars into the low to mid $20s, citing steadier growth and profitability assumptions. These revisions leave the stock trading on a slightly lower implied future P/E multiple, even though fair value estimates remain essentially unchanged.
User avatar
Mise à jour du récit • Jun 09

FIGS: International Expansion And 2026 Outlook Are Expected To Sustain Upside Potential

Analysts maintained FIGS' fair value estimate at $22.00, making modest adjustments to underlying assumptions such as a slightly lower discount rate and updated margin and growth inputs. These changes reflect refreshed research that incorporates recent price target increases from firms covering the stock.
User avatar
Mise à jour du récit • May 26

FIGS: International Expansion And Margin Recovery Will Support Future Upside Potential

Analysts have inched their FIGS fair value estimate down from $17.75 to $17.63, reflecting a slightly higher discount rate and lower future P/E assumptions, even as they continue to cite international expansion, product initiatives, and scale potential as key support for higher Street price targets in the stock around $17 to $20. Analyst Commentary Recent Street research on FIGS clusters around price targets in the mid-to-high teens, with several firms lifting targets as they reassess the company’s execution and growth opportunities.
User avatar
Mise à jour du récit • May 09

FIGS: International Expansion And Margin Recovery Will Drive Future Upside Potential

FIGS' analyst fair value estimate has been raised from $16.31 to $17.75 as analysts point to higher price targets following Q4 results that exceeded expectations, perceived progress on profitable growth, and ongoing opportunities in areas such as international expansion and product initiatives. Analyst Commentary Recent research on FIGS points to a mix of optimism around growth drivers and discipline on profitability, alongside some caution about margins returning to prior levels.
User avatar
Mise à jour du récit • Apr 21

FIGS: International Expansion And Q4 Execution Are Expected To Sustain Upside Potential

Analysts have lifted the FIGS fair value estimate from $20.00 to $22.00, reflecting higher modeled revenue growth, a richer future P/E multiple, and Street research that points to momentum following recent earnings and international expansion commentary. Analyst Commentary Recent Street commentary around FIGS has turned more constructive, with several bullish analysts adjusting their price targets higher and revisiting their views after the latest quarterly update.
User avatar
Mise à jour du récit • Apr 07

FIGS: International Expansion And Margin Recovery Efforts Will Drive Upside Potential

Narrative Update on FIGS The updated analyst price target for FIGS reflects a modest recalibration in the model inputs. Recent Street research citing Q4 outperformance, improving profitability and customer trends, and longer term opportunities around international expansion and scaling revenue helps explain why analysts continue to refine their $8 to $20 target range for the stock.
User avatar
Mise à jour du récit • Mar 24

FIGS: International Expansion And Margin Recovery Efforts Will Likely Cap Near Term Upside

Narrative Update on FIGS The analyst fair value estimate for FIGS has moved from $9.81 to $16.31 as analysts factor in a series of higher price targets and upgrades that highlight international expansion, margin recovery efforts, and what they describe as sustained recovery and strong momentum following recent Q4 results. Analyst Commentary Recent research on FIGS centers on how the company executes on growth opportunities while working to restore profitability metrics, with price target changes reflecting different views on how quickly that balance can be achieved.
User avatar
Mise à jour du récit • Mar 09

FIGS: Q4 Execution And Specialty Retail Tailwinds Are Expected To Drive Upside

The analyst fair value estimate for FIGS has increased to $20.00 from $15.00, as analysts point to Q4 earnings strength, improved profitability assumptions, and confidence that the company’s platform can support higher long term revenue potential. Analyst Commentary Recent research on FIGS has turned more constructive, with several bullish analysts revising their fair value views higher after the latest Q4 print and updated outlook.
User avatar
Mise à jour du récit • Feb 23

FIGS: Higher Multiple Assumptions Will Likely Limit Future Share Price Upside

Analysts have nudged their price expectations for FIGS higher, with a modest lift in fair value and future P/E assumptions helping to raise the average price target by about $0.50 as they factor in slightly stronger revenue growth and profit margin potential. Analyst Commentary Recent Street commentary around FIGS points to a mixed but generally constructive stance, with modest price target increases set against ongoing questions about execution and sector risks.
User avatar
Mise à jour du récit • Feb 09

FIGS: Demand Uncertainty In Specialty Retail Will Constrain Future Share Performance

Analysts have raised their FIGS fair value estimate from about $4.00 to roughly $6.20 per share. This reflects updated assumptions for revenue growth, profit margins, and the future P/E multiple that are in line with recent price target increases from firms such as Morgan Stanley, Barclays, and Roth Capital.
User avatar
Mise à jour du récit • Jan 25

FIGS: Raised Outlook Will Rely On Specialty Retail Tailwinds Into 2026

Narrative Update Analysts have inched up their price targets on FIGS into the high single digit to low double digit US$ range, citing recent research that points to more constructive views on specialty retail through 2026 and firm specific discussions that suggest ongoing business momentum. At the same time, our model keeps fair value steady at US$15.00, with slightly higher revenue growth, margin and future P/E assumptions.
User avatar
Mise à jour du récit • Jan 09

FIGS: Upgraded Outlook Hinges On Strong Brand And Healthcare Apparel Demand

Analysts have lifted their FIGS fair value estimate from US$8.00 to US$15.00, reflecting updated assumptions for revenue growth, profit margins and future P/E, along with a series of recent price target increases from Barclays, Roth Capital, Morgan Stanley, Goldman Sachs and BTIG. Analyst Commentary Recent Street research around FIGS has leaned more constructive, with several bullish analysts lifting price targets and initiating positive coverage.
User avatar
Mise à jour du récit • Dec 26

FIGS: Reduced Discounting Will Likely Cap Upside Despite Recent Business Momentum

Analysts have modestly lowered our FIGS fair value estimate to approximately $9.17 per share from about $9.53, even as they raise price targets into the mid single to low double digits. They cite stronger than expected post Q3 momentum, improving demand trends, and a richer future earnings multiple outlook, despite slightly softer long term growth and margin assumptions.
User avatar
Mise à jour du récit • Dec 12

FIGS: Recent Momentum Will Likely Fade As Reduced Discounting Limits Upside

Our FIGS fair value estimate increases to $9.53 from $8.78 as analysts lift price targets following stronger than expected Q3 results, sustained business momentum signals, and a more constructive view on the brand's long term earnings power. Analyst Commentary Street research on FIGS has turned more constructive overall, with several firms lifting price targets and initiating positive coverage following the company’s strong Q3 performance and improving demand indicators.
User avatar
Mise à jour du récit • Nov 27

FIGS: Share Price Will Likely Reflect Limited Upside Amid Market Caution

Analysts have raised their fair value estimate for FIGS from $7.74 to $8.78, citing stronger than expected business momentum, improved revenue growth expectations, and expanding profit margins. Analyst Commentary Recent research coverage of FIGS has provided a mix of constructive insights and measured caution as analysts adjust their expectations.
User avatar
Mise à jour du récit • Nov 13

FIGS: Future Competitive Pressures Will Likely Limit Further Upside

FIGS’ analyst price target has increased from $6.74 to $7.74 per share. Analysts point to stronger revenue growth expectations and positive trends within the healthcare apparel sector, which support the revised outlook.
Article d’analyse • Nov 11

There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 28% Price Jump

The FIGS, Inc. ( NYSE:FIGS ) share price has done very well over the last month, posting an excellent gain of 28%. The...
User avatar
Mise à jour du récit • Oct 30

FIGS: High Market Expectations May Limit Upside As Momentum Slows

Analysts have slightly reduced their price target for FIGS, lowering it from $6.74 to $6.74. The adjustment reflects steady business fundamentals and persistent confidence in the brand's strong positioning within the healthcare apparel market.
User avatar
Mise à jour du récit • Oct 15

Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success

Analysts have raised their price target for FIGS from $6.42 to $6.74, citing ongoing strength in U.S. healthcare apparel demand and a solid, debt-free balance sheet as supporting factors for the positive adjustment. Analyst Commentary Recent analyst coverage of FIGS has highlighted both encouraging trends and ongoing areas of caution regarding the company's growth trajectory and valuation.
User avatar
Mise à jour du récit • Aug 08

Healthcare, E-Commerce And Global Markets Will Fuel Long-Term Success

The notable upward revision in FIGS' fair value reflects improved consensus revenue growth expectations, more than offsetting the impact of a higher discount rate, resulting in an increased analyst price target from $4.86 to $5.85. What's in the News FIGS, Inc.
Article d’analyse • Jun 30

There's Reason For Concern Over FIGS, Inc.'s (NYSE:FIGS) Massive 35% Price Jump

FIGS, Inc. ( NYSE:FIGS ) shareholders have had their patience rewarded with a 35% share price jump in the last month...
Article d’analyse • May 29

It Looks Like FIGS, Inc.'s (NYSE:FIGS) CEO May Expect Their Salary To Be Put Under The Microscope

Key Insights FIGS to hold its Annual General Meeting on 4th of June CEO Trina Spear's total compensation includes...
Article d’analyse • May 09

Subdued Growth No Barrier To FIGS, Inc. (NYSE:FIGS) With Shares Advancing 40%

Those holding FIGS, Inc. ( NYSE:FIGS ) shares would be relieved that the share price has rebounded 40% in the last...
Article d’analyse • May 03

Is Now The Time To Look At Buying FIGS, Inc. (NYSE:FIGS)?

FIGS, Inc. ( NYSE:FIGS ), might not be a large cap stock, but it led the NYSE gainers with a relatively large price...
Seeking Alpha • Apr 24

FIGS, Inc.: Recommending A Hold Despite Tailwinds

Summary FIGS, Inc. is recommended as a “HOLD” due to subpar financial performance and limited upside potential, despite growth plans and strong social media presence. Expansion into untapped markets and new physical stores, particularly in Philadelphia, are key business drivers for FIGS’ future growth. Financial analysis reveals significant declines in EBITDA, net income, and free cash flow, with only a slight increase in net revenue. Tariff risks pose substantial threats to FIGS, potentially increasing production costs and affecting profit margins and demand. Read the full article on Seeking Alpha
Article d’analyse • Mar 06

FIGS' (NYSE:FIGS) Soft Earnings Don't Show The Whole Picture

The most recent earnings report from FIGS, Inc. ( NYSE:FIGS ) was disappointing for shareholders. While the headline...
Seeking Alpha • Mar 06

Figs, Inc. - Slow Growth Is Still Growth

Summary Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO. Superior product quality and brand loyalty, coupled with strategic cash reserves, position Figs, Inc. for steady growth and revenue expansion. Read the full article on Seeking Alpha
Article d’analyse • Jan 30

Be Wary Of FIGS (NYSE:FIGS) And Its Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Seeking Alpha • Dec 12

FIGS: Enter A White Knight?

Summary FIGS, Inc. faces stagnating sales and plummeting earnings, with recent Q3/2024 revenues shrinking by 1.5% YoY and operating losses mounting. Private equity firm Story3 Capital Partners is rumored to have offered $6 a share for FIGS, causing a pre-market rally; investors should take advantage and sell their shares. FIGS' valuation may be attractive to Story3, trading at 1.2x Fwd EV/Sales, compared to 2.4x for Nike and 4.6x for Lululemon. Management's diversification efforts have failed; a focus on international DTC medical scrubs could be a winning strategy under new ownership. Read the full article on Seeking Alpha
Seeking Alpha • Nov 13

FIGS Back To Q1 Prices, But The Name Is Still A Hold

Summary Figs reported disappointing 3Q24 results with a 2% revenue decline and a 13 percentage point drop in adjusted EBITDA margins, leading to a 30% stock price drop. The company's high SG&A expenses and lack of growth make it difficult to compete against lower-priced alternatives, justifying my Hold rating. Questionable $25 million investment in a pre-product healthcare education app raises concerns about capital allocation and potential conflicts of interest. Despite a great product, Figs' lack of expense control and high valuation make it an unattractive investment at current prices. Read the full article on Seeking Alpha
Article d’analyse • Nov 10

The Price Is Right For FIGS, Inc. (NYSE:FIGS) Even After Diving 26%

FIGS, Inc. ( NYSE:FIGS ) shares have had a horrible month, losing 26% after a relatively good period beforehand. The...

Ventilation des recettes et des dépenses

Comment FIGS gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

NYSE:FIGS Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 26710624210
31 Mar 26666414010
31 Dec 25631343820
30 Sep 25581183670
30 Jun 2557073730
31 Mar 2556113760
31 Dec 2455633730
30 Sep 24549113640
30 Jun 24551193480
31 Mar 24545223420
31 Dec 23546233430
30 Sep 23546163550
30 Jun 23532143470
31 Mar 23516143340
31 Dec 22506213170
30 Sep 22490302950
30 Jun 22464332790
31 Mar 22443-123090
31 Dec 21420-102900
30 Sep 21381-102680
30 Jun 2135522360
31 Mar 21318571580
31 Dec 20263501320
31 Dec 191100800

Des revenus de qualité: FIGS a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de FIGS sont plus élevées que l'année dernière FIGS. (8.7%) sont plus élevées que l'année dernière (1.3%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de FIGS ont augmenté de manière significative de 33.5% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de FIGS au cours de l'année écoulée ( 762.2% ) dépasse sa moyenne sur 5 ans ( 33.5% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices FIGS au cours de l'année écoulée ( 762.2% ) a dépassé celle du secteur Luxury 29.8%.


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de FIGS ( 14% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/09/18 10:43
Cours de l'action en fin de journée2026/09/18 00:00
Les revenus2026/06/30
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
  • Formulaire 10-K de la SEC
  • Formulaire 10-Q de la SEC
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
  • Rapports de recherche des analystes
  • Blue Matrix
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
  • Données de marché ICE
  • Formulaire S-1 de la SEC
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
  • Formulaire 4 de la SEC
  • Formulaire 13D de la SEC
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
  • Formulaire 10-K de la SEC
  • Formulaire SEC DEF 14A
Principaux développements10 ans
  • Annonces de l'entreprise
  • Formulaire 8-K de la SEC

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

FIGS, Inc. est couverte par 14 analystes. 8 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Adrienne Yih-TennantBarclays
Robert DrbulBTIG
Brooke RoachGoldman Sachs

Prenez de meilleures décisions d’investissement partout

Scannez pour télécharger
Ouvrir l’App StoreOuvrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Voir les sources de données
Marchés
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idées d'investissement
  • Sociétés sous-évaluées
  • Les géants du dividende
  • Achats d'initiés
  • Énergie nucléaire
  • Véhicules autonomes
  • Intelligence artificielle
  • Cryptomonnaie et blockchain
  • cybersécurité
  • Plus d'idées
Communautés boursières
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Outils et fonctionnalités
  • Suivi de portefeuille
  • Filtre et alertes sur les actions
  • Narratives et valeurs équitables
  • Calculateur de dividendes
Actualités et découvertes
  • Dernières actualités de stock
  • Aperçus du marché mondial
  • Le Foxhole
  • Idées d'investissement
  • Narratives de la communauté
  • Quoi de neuf
Simply Wall St
  • Plans et tarifs
  • Publicité
  • À propos de nous
  • Nous contacter
  • Carrières
  • Centre d'aide
  • Apprendre à investir en bourse
  • Programme d'affiliation
  • Affaires et entreprises
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Conditions générales d'utilisation
  • Politique de confidentialité
  • Conditions relatives à l'IA
  • Guide des services financiers